{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:47:56Z","timestamp":1790380076683,"version":"4.1.0"},"reference-count":41,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2003,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>To determine if stimulation of Th1-cell-associated immune responses, mediated by interleukin 12 (IL-12) and gamma interferon (IFN-\u03b3), enhance the antileishmanial effect of amphotericin B (AMB),<jats:italic>Leishmania donovani<\/jats:italic>-infected BALB\/c mice were first treated with (i) exogenous IL-12 to induce IFN-\u03b3, (ii) agonist anti-CD40 monoclonal antibody (MAb) to maintain IL-12 and induce IFN-\u03b3, or (iii) anti-IL-10 receptor (IL-10R) MAb to blockade suppression of IL-12 and IFN-\u03b3. In animals with established visceral infection, low-dose AMB alone (two injections of 1 mg\/kg of body weight; total dose, 2 mg\/kg) killed 15 to 29% of liver parasites; by themselves, the immunointerventions induced 16 to 33% killing. When the interventions were combined, the leishmanicidal activities increased 3.4-fold (anti-CD40), 6.3-fold (anti-IL-10R), and 9-fold (IL-12) compared with the activities of AMB plus the control preparations; and overall killing (76 to 84%) approximated the 84 to 92% killing effect of 7.5-fold more AMB alone (three injections of 5 mg\/kg; total dose, 15 mg\/kg). These results suggest that strengthening the host Th1-cell response may be a strategy for the development of AMB-sparing regimens in visceral leishmaniasis.<\/jats:p>","DOI":"10.1128\/aac.47.8.2513-2517.2003","type":"journal-article","created":{"date-parts":[[2003,7,23]],"date-time":"2003-07-23T19:24:32Z","timestamp":1058988272000},"page":"2513-2517","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":62,"title":["Immunoenhancement Combined with Amphotericin B as Treatment for Experimental Visceral Leishmaniasis"],"prefix":"10.1128","volume":"47","author":[{"given":"Henry W.","family":"Murray","sequence":"first","affiliation":[{"name":"Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine B.","family":"Brooks","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"DeVecchio","sequence":"additional","affiliation":[{"name":"Center for Global Health and Disease, Case Western University School of Medicine, Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick P.","family":"Heinzel","sequence":"additional","affiliation":[{"name":"Center for Global Health and Disease, Case Western University School of Medicine, Cleveland, Ohio 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.4049\/jimmunol.162.6.3633","volume":"162","year":"1999","unstructured":"Balkhy, H. H., and F. P. Heinzel. 1999. Endotoxin fails to induce interferon-\u03b3 in endotoxin tolerant mice: deficiencies in both IL-12 heterodimer production and IL-12 responsiveness. J. Immunol.162:3633-3638.","journal-title":"J. Immunol."},{"key":"e_1_3_2_3_2","unstructured":"Bennett J. E. 2001. Amphotericin B p. 1295-1299. In J. C. Hardman and L. E. Limbird (ed.) Goodman & Gilman's the pharmacological basis of therapeutics 10th ed. McGraw-Hill New York N.Y."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/142.1.83"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.4.625"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0008-8749(77)90145-9","volume":"33","year":"1977","unstructured":"Blanke, T. J., J. R. Little, S. F. Shirley, and R. G. Lynch. 1977. Augmentation of murine immune responses by amphotericin B. Cell. Immunol.33:180-190.","journal-title":"Cell. Immunol."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1086\/514027"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<203::AID-IMMU203>3.0.CO;2-B"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199802)28:02<525::AID-IMMU525>3.0.CO;2-M"},{"key":"e_1_3_2_11_2","first-page":"1723","volume":"62","year":"1999","unstructured":"Groux, H., F. Cottrez, M. Rouleau, S. Mauze, S. Aantonenko, S. Hurst, T. McNeil, M. Bigler, M.-G. Roncarolo, and R. L. Coffman. 1999. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol.62:1723-1729.","journal-title":"J. Immunol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/107999000312748","volume":"20","year":"2000","unstructured":"Lehmann, J., K. H. Enssle, I. Lehmann, A. Emmendorfer, and M. L. Lohmann-Matthes. 2000. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice J. Interferon Cytokine Res.20:63-77.","journal-title":"Interferon Cytokine Res."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/infdis\/171.2.406","volume":"171","year":"1995","unstructured":"Louie, A., A. L. Baltch, and R. P. Smith. 1995. Fluconazole and amphotericin B antifungal therapies do not negate the protective effect of endogenous tumor necrosis factor in a murine model of fatal disseminated candidiasis. J. Infect. Dis.171:406-415.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_14_2","first-page":"779","volume":"64","year":"2000","unstructured":"Martin, D. L., C. L. King, E. Pearlman, E. Strine, and F. P. Heinzel. 2000. IFN-\u03b3 is necessary but not sufficient for anti-CD40 antibody-mediated inhibition of the Th2 response to Schistosoma mansoni eggs. J. Immunol.64:779-785.","journal-title":"J. Immunol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.1.18-27.1998"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1006\/expr.2001.4640"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1086\/315277"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.3.1058-1063.1994"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.683"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.8.1825"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/157.5.973"},{"key":"e_1_3_2_22_2","first-page":"1254","volume":"83","year":"1989","unstructured":"Murray, H. W., M. J. Oca, A., M. Granger, and R. D. Schreiber. 1989. Successful response to chemotherapy in experimental visceral leishmaniasis: requirement for T cells and effect of lymphokines. J. Clin. Investig.83:1254-1259.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.7.1504"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.1.387"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.5.867"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1086\/315890"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.1.288-293.2000"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.8.2185-2197.2001"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2613.2001.00199.x","volume":"82","year":"2001","unstructured":"Murray, H. W. 2001. Tissue granuloma structure-function in experimental visceral leishmaniasis. Int. J. Exp. Pathol.82:249-276.","journal-title":"Int. J. Exp. Pathol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.11.6284-6293.2002"},{"key":"e_1_3_2_31_2","unstructured":"Murray H. W. A. L. Moreira C. M. Lu J. L. DeVecchio M. Matsuhashi X. Ma and F. P. Heinzel. Determinants of response to interleukin 10 receptor blockade immunotherapy in experimental visceral leishmaniasis. J. Infect. Dis. in press."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-4758(96)10078-8"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1086\/314495","volume":"178","year":"1998","unstructured":"Rogers, P. D., J. K. Jenkins, S. W. Chapman, K. Ndebele, B. A. Chapman, and J. D. Cleary. 1998. Amphotericin B activation for human genes encoding for cytokines. J. Infect. Dis.178:1726-1733.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.63.12.4894-4899.1995"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200003)30:3<834::AID-IMMU834>3.0.CO;2-9"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1086\/317537"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/516362"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(96)10060-I"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.10.2228"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/42.4.469"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.5.1296-1300.1990"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.8.2513-2517.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.47.8.2513-2517.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T09:58:06Z","timestamp":1704880686000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.47.8.2513-2517.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["10.1128\/AAC.47.8.2513-2517.2003"],"URL":"https:\/\/doi.org\/10.1128\/aac.47.8.2513-2517.2003","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]},"assertion":[{"value":"2003-02-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-05-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}